A decision about whether to resume administering the Johnson & Johnson Covid-19 vaccine should come this Friday, when an expert panel that is advising the Centers for Disease Control and Prevention is scheduled to meet, according to Dr. Anthony S. Fauci, the nation’s leading infectious disease expert.
“I think by that time we’re going to have a decision,” Dr. Fauci said on Sunday on the CNN program “State of the Union.”
“I don’t want to get ahead of the C.D.C. and the F.D.A. and the advisory committee,” he added, but said he expected experts to recommend “some sort of either warning or restriction” on the use of the vaccine.
Federal health agencies recommended putting injections of the vaccine on pause on Tuesday while they investigated whether it was linked to a rare blood-clotting disorder. All 50 states,Washington, D.C., and Puerto Rico have stopped administering the vaccine.
The unusual disorder includes blood clots in the brain combined with low levels of platelets, blood cells that typically promote clotting. The combination, which can cause clotting and bleeding at the same time, was initially documented in six women between the ages of 18 and 48 who had received the vaccine one to three weeks prior. One of the women died, and another was hospitalized in critical condition.
This pattern has prompted questions about whether vaccinations could resume in men or in older people. But because women fill more of the health care jobs for which vaccinations have been prioritized, it is not clear how much the problem might affect men, too. On Wednesday, two more cases of the clotting disorder were identified, including one in a man who had received the vaccine in a clinical trial.
About 131.2 million people in the United States have received at least one dose of a Covid-19 vaccine, or roughly half of all American adults, according to the C.D.C. More than seven million of those people have received Johnson & Johnson’s shot. If there is a link between the vaccine and the clotting disorder, the risk remains extremely low, experts say.
“It’s an extraordinarily rare event,” Dr. Fauci said on the ABC program “This Week.” The pause was intended to give experts time to gather more information and to warn physicians about the clotting disorder so that they can make more informed treatment decisions, said Dr. Fauci, who appeared on four TV news programs on Sunday morning.
European regulators have been investigating similar cases of the unusual clotting disorder in people who have received the AstraZeneca vaccine. Some European countries have since stopped administering that vaccine altogether, while others have restricted its use in younger people.
Dr. Fauci also expressed frustration that “a disturbingly large proportion of Republicans,” who have been critical of many coronavirus restrictions, have expressed a reluctance to be vaccinated. “It’s almost paradoxical,” he said. “On the one hand they want to be relieved of the restrictions, but on the other hand, they don’t want to get vaccinated. It just almost doesn’t make any sense.”
- On April 13, 2021, U.S. health agencies called for an immediate pause in the use of Johnson & Johnson’s single-dose Covid-19 vaccine after six recipients in the United States developed a rare disorder involving blood clots within one to three weeks of vaccination.
- All 50 states, Washington, D.C. and Puerto Rico temporarily halted or recommended providers pause the use of the vaccine. The U.S. military, federally run vaccination sites and a host of private companies, including CVS, Walgreens, Rite Aid, Walmart and Publix, also paused the injections.
- Fewer than one in a million Johnson & Johnson vaccinations are now under investigation. If there is indeed a risk of blood clots from the vaccine — which has yet to be determined — that risk is extremely low. The risk of getting Covid-19 in the United States is far higher.
- The pause could complicate the nation’s vaccination efforts at a time when many states are confronting a surge in new cases and seeking to address vaccine hesitancy.
- Johnson & Johnson has also decided to delay the rollout of its vaccine in Europe amid concerns over rare blood clots, dealing another blow to Europe’s inoculation push. South Africa, devastated by a more contagious virus variant that emerged there, suspended use of the vaccine as well. Australia announced it would not purchase any doses.
The New York Times examined survey and vaccine administration data for nearly every U.S. county and found that both willingness to receive a vaccine and actual vaccination rates to date were lower, on average, in counties where a majority of residents voted to re-elect former President Donald J. Trump in 2020.
Dr. Fauci said that he expected all high school students to become eligible for vaccination before school begins in the fall, with younger children eligible no later than the first quarter of 2022.